|Horizon||30 Days Login to change|
Virtus LifeSci Market Sensitivity
|As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Virtus LifeSci will likely underperform.One Month Beta |Analyze Virtus LifeSci Biotech Demand TrendCheck current 30 days Virtus LifeSci correlation with market (DOW)|
β = 1.2326
Virtus LifeSci Biotech Technical Analysis
Virtus LifeSci Projected Return Density Against MarketConsidering 30-days investment horizon, the etf has beta coefficient of 1.2326 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are expected to be negative, Virtus LifeSci will likely underperform. Additionally, Virtus LifeSci Biotech Clinical Trls ETF has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming DOW
Predicted Return Density
Virtus LifeSci Return VolatilityVirtus LifeSci Biotech Clinical Trls ETF has volatility of 2.1092% on return distribution over 30 days investment horizon. DOW inherits 1.0678% risk (volatility on return distribution) over the 30 days horizon.